ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report

Informations

• Publié par: researchmoz
• Nombre de lectures: 7
• Langue: English

Extrait

ResearchMoz: Bone Metabolism Therapeutics

Market to 2018 - Hyperparathyroidism Sector to

Decline in the Absence of New Product

Launches and Increased Generic Erosion for

Zemplar, Hectorol and Sensipar- Market

Research Report

PR Newswire

ALBANY, New York, June 19, 2012

ALBANY, New York

,

June 19, 2012

/PRNewswire/ --

New Report Added in ResearchMoz Reports Database Bone

Metabolism Therapeutics Market to 2018 - Hyperparathyroidism

Sector to Decline in the Absence of New Product Launches and

Increased Generic Erosion for Zemplar, Hectorol and Sensipar

GBI Research, the leading business intelligence provider, has released its latest

research, Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism

Sector to Decline in the Absence of New Product Launches and Increased

Generic Erosion for Zemplar, Hectorol and Sensipar, which provides insights

into bone metabolic disease therapeutics until 2018.

To Browse Full TOC, Tables & Figures

visit:

http://www.researchmoz.com/bone-metabolism-therapeutics-

market-to-2018-hyperparathyroidism-sector-to-decline-in-the-

absence-of-new-product-launches-and-increased-generic-erosion-for-

zemplar-hectorol-and-sensipar-report.html

The report is built using data and information sourced from proprietary

databases, primary and secondary research and in-house analysis by GBI

Researchs team of industry experts. The report provides an in-depth analysis of

the major bone metabolic diseases, including osteoporosis, Pagets disease of

bone, hyperparathyroidism and bone metastases. The report also provides the

share of generics in global bone metabolic diseases as well as in each indication

market. It also provides the treatment algorithm flow for each of the four

indications. The report examines the global bone metabolic diseases treatment

usage patterns. In addition, the geographical distribution of bone metabolic

diseases and markets across the US, the top five countries of

Europe

, and in

Japan

, are provided in the report. The report also includes insights into the bone

metabolic diseases R&D product pipeline and explores the competitive

landscape, including major players in the bone metabolism therapeutics

market. Finally, the report also includes analysis of Mergers and Acquisitions

(M&As) and licensing agreements that took place in the bone metabolism

therapeutics market.

Related Market Research Reports on

Bone Market

Bone Cancer Pipeline Review

Optimizing Treatment for Bone Metastases in Patients with Advanced

Cancers

Bone Metastasis Global Clinical Trials Review

Bone Cancer Global Clinical Trials Review

Bone Graft Substitutes

ENT Devices Market

Bone Metastases Therapeutics - Pipeline Assessment

Bone and Joint Infection Market

Pagets disease of Bone

GBI Researchs analysis shows that the overall global bone metabolism

therapeutics market for the four indications (which includes osteoporosis,

Pagets disease of bone, hyperparathyroidism and bone metastases) was valued

at

$15 billion

in 2010, growing from

$10.1 billion

in 2002 and indicating a CAGR

of 5.2%. GBI Research forecasts the market to grow at a CAGR of 7.7%

between 2010 and 2018 to record a sales value of

$27.1 billion

by 2018. The

growth in the bone metabolism therapeutics market is mainly due to the

contribution of osteoporosis market. The revenue of osteoporosis market alone

has approximately 68% of the total bone metabolism revenue. So, the global

bone metabolism market is growing inspite of the declining market nature of

the rest of therapeutics areas discussed here.

Scope

- Data and analysis on the metabolic disorder therapeutics market in the

leading geographies of the world the US, the UK,

Germany

,

France

,

Italy

,

Spain

,

and

Japan

.

- Annualized market data for the metabolic disorder therapeutics market from

2002 to 2010, with forecasts to 2018 for the three indications osteoporosis,

Pagets disease of bone, hyperparathyroidism and bone metastases.

- Market data on the geographical landscape and therapeutic landscape,

including market size, market share, annual cost of therapy, sales volume and

treatment usage patterns such as disease population, treatment seeking

population, diagnosis population and prescription population.

- Share of the generics in the global bone metabolism therapeutics market and

for the market of each indication that is covered in the report.

- Key drivers and restraints that have had a significant impact on the market.

- The competitive landscape of the global bone metabolism therapeutics

market, including top companies benchmarking. The key companies studied in

this report are Amgen Inc., Abbott Laboratories, Genzyme Corporation, Merck

& Co. Inc. and Novartis AG.

- Key M&A activities and Licensing Agreements that took place in 2009 and

2011 in the metabolic disorders therapeutics market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.

- Build effective strategies to launch their pipeline products by identifying

potential geographies.

- Exploit in-licensing and out-licensing opportunities by identifying products that

might fill their portfolio gaps.

- Develop key strategic initiatives by studying the key strategies of top

competitors.

- Devise a more tailored country strategy through the understanding of key

drivers and barriers and market potential of each indication.

- Develop market-entry and market expansion strategies by identifying the

geographic markets poised for strong growth.

- Reinforce R&D pipelines by identifying new target mechanisms which can

produce first-in-class molecules which are safer and more efficacious.

Report Category:

Pharmaceutical

Browse All

GBI Research Latest Reports & Industry Analysis

Latest Reports by GBI Research

Pharmaceutical Pricing and Reimbursement in China

Emerging Pharmaceutical Market in South Africa

Translational Regenerative Medicine Market

Workforce Reductions in Pharmaceuticals

Re-evaluating Pharmaceutical Pipelines

Biological Strategies in the Emerging Markets

Negative Pressure Wound Therapy Market

Ambient Energy Harvesters Market

Pico Projectors Market

Acrylonitrile Global Market

Advanced Batteries Market

Emerging Pharmaceutical Market in Indonesia and Philippines

Polyethylene Terephthalate (PET) Global Market

Prescribing Trends in Opioids

Drug Price Cuts in Top Five Countries of Europe

Pricing and Reimbursement in Brazil

Generics in Cardiovascular Diseases Market

Antibacterials Market

Arthritis Therapeutics Market

Patient Perspectives

Coal Mining Market

Iron Ore Mining Market in Europe

About Us

ResearchMoz is the one stop online destination to find and buy market research

reports & Industry Analysis. We fulfill all your research needs spanning across

industry verticals with our huge collection of market research reports. We

provide our services to all sizes of organizations and across all industry verticals

and markets. Our Research Coordinators have in-depth knowledge of reports

as well as publishers and will assist you in making an informed decision by

giving you unbiased and deep insights on which reports will satisfy your needs

at the best price.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY

12207

Tel: [phone]

USA

- Canada Toll Free: 866-997-4948

Email

:

[e-mail]

http://www.researchmoz.com/

http://www.marketresearchreportsblog.com/

http://www.researchmoz.com/niche-market.html